Bloomberg @business
Lundbeck should lose its fight against a $105 million antitrust fine for so-called pay-for-delay deals that stalled sales of cheaper generic versions of one of its drugs, says an adviser to the EU’s top court https://t.co/opUYKzmnfy — PolitiTweet.org